Improving Survival in Patients with High-Risk and Metastatic Melanoma: Immunotherapy Leads the Way

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.4, Iss.5, 2003-01, pp. : 333-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Medical Emergency Team: a new strategy to identify and intervene in high-risk patients

By HOURIHAN F BISHOP G HILLMAN K M DAFFURN K

Clinical Intensive Care, Vol. 6, Iss. 6, 1995-12 ,pp. : 269-269

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Vemurafenib: In Unresectable or Metastatic Melanoma

By Keating Gillian M.

BioDrugs, Vol. 26, Iss. 5, 2012-10 ,pp. : 325-334

Adis International

Access to resources Recommend Favorite

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

Annals Of Clinical And Translational Neurology, Vol. 4, Iss. 12, 2017-12 ,pp. : 909-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost Effectiveness of a High-Risk Pregnancy Program

By Alexander Judith W. Mackey Marlene C.

Care Management Journals, Vol. 1, Iss. 3, 1999-01 ,pp. : 170-174

Springer Publishing Company

Access to resources Recommend Favorite

High bed occupancy rates: Are they a risk for patients and staff?

By Volpe Fernando Madalena Magalhães Adriana Carla de Miranda Rocha André Ramos

International Journal of Evidence-based Healthcare, Vol. 11, Iss. 4, 2013-12 ,pp. : 312-316

Blackwell Publishing

Access to resources Recommend Favorite